Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.
Clinical trial NCT03575702 · COMPLETED
Trial details
- NCT number
- NCT03575702
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-18
- Primary completion
- 2017-08-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.